Thursday 8th November 2018
A research collaboration between the Royal Free and Royal Brompton hospitals, funded by Scleroderma and Raynaud’s UK (SRUK), is investigating if reflux from the stomach into the oesophagus plays a role in lung scarring in scleroderma patients.
Tuesday 6th November 2018
Keloid morphea is a rare, and hence poorly understood, form of localised scleroderma that only affects the skin. A new study into the condition has the potential to make a huge beneficial impact on our community.
Friday 2nd November 2018
Over the years, many people living with Raynaud’s have advocated for the use of Chinese acupuncture and Chinese acupressure, but do they actually help?
Tuesday 30th October 2018
Fibrosis is often the fundamental reason of morbidity and mortality in systemic scleroderma, however there is no effective therapy to prevent this process. A new study has identified a protein that may trigger fibrosis.
Wednesday 17th October 2018
A study from Japan has devised a test which researchers claim could prove whether a patient has primary or secondary Raynaud’s.
Tuesday 25th September 2018
SRUK have made a significant contribution in providing funding for this two-year pilot study, which is well underway. Initial results are promising, and the success of the study means that the implantable loop recorder can then be examined through a wider clinical study.
Friday 21st September 2018
Dr. Victoria Flower, based in Bath, is working on a new research project, fully entitled, ‘The role of Hypoxia Inducible Factor and Vascular Endothelial Growth Factor in microvascular dysfunction and fibrosis in Systemic sclerosis’, to examine factors that may be affecting blood flow in people with Scleroderma and Raynaud’s.
Friday 14th September 2018
A team led by Sabrina Munir at King’s College London has found that the presence of single nucleotide polymorphisms (SNPs) may be indicative of Raynaud's Phenomenon or act as a measure of how likely the individual is to develop the condition.
Friday 24th August 2018
Slightly older ears may remember the days of ‘CREST’, the now outdated term for Scleroderma. But what did ‘CREST’ mean? Why was it used? And why was the term abandoned in mainstream medical practice?
Monday 20th August 2018
It’s been well established that women are more likely to be affected by Raynaud’s phenomenon than men but why? Let's look into the reasons behind this.
